Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hemispherx Biopharma has signed an agreement with Armada Health Care to market Alferon N Injection.
Subscribe to our email newsletter
The tie up allows Hemispherx to manufacture and supply Alferon N Injection to physicians and patients by using Armada’s national network of specialty pharmacies.
Additionally, BioRidge Pharma (BRP) will warehouse, ship, and distribute Alferon N Injection on an exclusive basis for US markets.
Hemispherx Operations senior vice president Wayne Springate said the company is upgrading its manufacturing facility in New Brunswick, New Jersey, to include a high volume, bioreactor to manufacture Alferon N Injection.